• WuXi Biologics filed a next-day disclosure return on Sept. 9, 2026, reporting 1,200,000 new ordinary shares issued.
• Shares were issued from exercise of options under its Pre-IPO Share Option Scheme at HKD 2.64 per share.
• Issued shares rose to 4,155,933,877 as of Sept. 9, 2026, from 4,154,733,877 on Sept. 7, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260909-12326674), on September 09, 2026, and is solely responsible for the information contained therein.